相关实验视频

Updated: Jun 17, 2025

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection

Published on: September 14, 2019

针对Cryptosporidium的新兴治疗途径:全面审查

Munwar Ali¹, Chang Xu¹, Jia Wang¹

¹Institute of Traditional Chinese Veterinary Medicine, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China.

Veterinary parasitology

|August 8, 2024

概括

菌体感染是全球主要的健康问题,治疗选择有限. 研究正在探索遗传工具和天然产品,以开发有效,安全和负担得起的治疗方法来对抗这种寄生虫.

科学领域:

寄生虫学的寄生虫学
传染性疾病传染性疾病
药物发现药物发现药物发现

背景情况:

杆菌对人类和牲畜造成严重的腹疾病,给公共卫生和经济带来了重大挑战.
目前的治疗方法,如帕罗莫米辛是不可靠的,和尼塔佐化 (NTZ) 在弱势群体,包括儿童和艾滋病毒/艾滋病感染者 (PLWHA) 的有效性有限.
寄生虫独特的生物学和基因操纵方面的挑战阻碍了药物开发.

研究的目的:

审查目前对密码化症的治疗限制.
探索先进的遗传工具和自然产品的潜力,以发现新药.
确定开发安全,有效和负担得起的加密菌病治疗方法的策略.

主要方法:

对现有治疗选择及其局限性的文献综述.
讨论新兴技术,包括用于功能基因研究的CRISPR/Cas-9基因组编辑.
探索草药和天然产品作为潜在的治疗剂.

主要成果:

对于Cryptosporidium的现有疗法是不够的,在有效性和可访问性方面存在重大限制.
通过功能基因组学,CRISPR/Cas-9技术为通过功能基因组学识别药物标提供了一个有前途的途径.
草药药物显示出治疗密码菌病的潜力,这是由于对抗虫药物耐药性的担忧所致.

结论:

迫切需要新的药物来对抗全球加密菌病的负担.
将遗传方法与天然产品研究结合起来,可能会产生有效且易于获得的治疗方法.
对基因操纵平台和天然产品疗效的进一步研究对于开发下一代疗法至关重要.

关键词:

这就是CRISPR/Cas9的作用.这就是Cryptosporidium.毒品的目标是毒品.一个健康的健康.传统兽医的传统兽医医学

更多相关视频

A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.

A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.

Published on: July 9, 2012

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

相关概念视频

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...